{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T13:09:49Z","timestamp":1788700189572,"version":"build-2803163510"},"reference-count":150,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ophthalmology"],"DOI":"10.1080\/08820538.2026.2727974","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:50:35Z","timestamp":1788699035000},"page":"1-18","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Sclerotherapy in Orbital and Peri-Orbital Pathology: A Systematic Review of Current Applications and Emerging Frontiers"],"prefix":"10.1080","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-3275","authenticated-orcid":false,"given":"Ayushi","family":"Agarwal","sequence":"first","affiliation":[{"name":"Royal Adelaide Hospital","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Sinha","sequence":"additional","affiliation":[{"name":"Indira Gandhi Institute of Medical Sciences","place":["Patna, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman A.","family":"Khan","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Y.","family":"Tong","sequence":"additional","affiliation":[{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Selva","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital","place":["Adelaide, Australia"]},{"name":"Adelaide University","place":["Adelaide, Australia"]},{"name":"Adelaide University","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0268355518798283"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(63)90313-X"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-19810201-16"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2017.03.007"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001195"},{"issue":"6","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000495248","article-title":"Results of intralesional bleomycin sclerotherapy for treatment of orbital lymphangiomas at a tertiary eye care centre in Bangladesh","volume":"5","author":"Nuruddin M","year":"2019","unstructured":"Nuruddin M, Roy SR, Mudhar HS. Results of intralesional bleomycin sclerotherapy for treatment of orbital lymphangiomas at a tertiary eye care centre in Bangladesh. Ocul Oncol Pathol. 2019;5(6):412\u2013417.","journal-title":"Ocul Oncol Pathol"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31829bb4a9"},{"issue":"3","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2005-921954","article-title":"Injection sclerotherapy","volume":"22","author":"Worthington-Kirsch RL","year":"2005","unstructured":"Worthington-Kirsch RL. Injection sclerotherapy. Semin Intervent Radiol. 2005;22(3):209\u2013217.","journal-title":"Semin Intervent Radiol"},{"issue":"5","key":"e_1_3_4_10_1","first-page":"473","article-title":"Death following injection of sodium morrhuate","volume":"65","author":"Peller JA","year":"1951","unstructured":"Peller JA, Gunton RW. Death following injection of sodium morrhuate. Can Med Assoc J. 1951;65(5):473\u2013475.","journal-title":"Can Med Assoc J"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12355"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21070862"},{"issue":"4","key":"e_1_3_4_13_1","first-page":"e20230048","article-title":"Histopathological changes of lymphatic malformation after bleomycin injection","volume":"86","author":"Al-Faky YH","year":"2023","unstructured":"Al-Faky YH, Alkatan HM. Histopathological changes of lymphatic malformation after bleomycin injection. Arq Bras Oftalmol. 2023;86(4):e20230048.","journal-title":"Arq Bras Oftalmol"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2007.10.009"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.5114\/pr.2021.106557"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042728-200101000-00017"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780903376163"},{"issue":"9","key":"e_1_3_4_18_1","first-page":"1182","article-title":"Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate","volume":"86","author":"Neeman A","year":"1991","unstructured":"Neeman A, Leiser A, Kadish U. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate. Am J Gastroenterol. 1991;86(9):1182\u20131184.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1524-4725.2011.01897.x","article-title":"Ethanolamine oleate: a dangerous and outmoded sclerosant","volume":"37","author":"Duffy DM","year":"2011","unstructured":"Duffy DM. Ethanolamine oleate: a dangerous and outmoded sclerosant. Dermatologic Surg. 2011;37(3):402.","journal-title":"Dermatologic Surg"},{"issue":"2","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5469\/neuroint.2011.6.2.84","article-title":"Direct Percutaneous alcohol sclerotherapy for venous malformations of head and neck region without fluoroscopic guidance: technical consideration and outcome","volume":"6","author":"Baek HJ","year":"2011","unstructured":"Baek HJ, Hong JP, Choi JW, Suh DC. Direct Percutaneous alcohol sclerotherapy for venous malformations of head and neck region without fluoroscopic guidance: technical consideration and outcome. Neurointervention. 2011;6(2):84\u201388.","journal-title":"Neurointervention"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000113"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.3171\/CASE23132"},{"key":"e_1_3_4_24_1","first-page":"Doc09","article-title":"Reversal of vision after bleomycin injection in orbital lymphangioma","volume":"12","author":"Devi Nivean P","year":"2022","unstructured":"Devi Nivean P, Madhivanan N. Reversal of vision after bleomycin injection in orbital lymphangioma. GMS Ophthalmol Cases. 2022;12:Doc09.","journal-title":"GMS Ophthalmol Cases"},{"issue":"1","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/DSS.0000000000003220","article-title":"Bleomycin electrosclerotherapy treatment in the management of vascular malformations","volume":"48","author":"Kostusiak M","year":"2022","unstructured":"Kostusiak M, Murugan S, Muir T. Bleomycin electrosclerotherapy treatment in the management of vascular malformations. Dermatol Surg. 2022;48(1):67\u201371.","journal-title":"Dermatol Surg"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2015.11.050"},{"issue":"4","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.36351\/pjo.v41i4.2128","article-title":"Percutaneous sclerotherapy with bleomycin for orbital lymphangioma: a case report","volume":"41","author":"Tanveer T","year":"2025","unstructured":"Tanveer T, Ahmad S, Tahir F, Akram F. Percutaneous sclerotherapy with bleomycin for orbital lymphangioma: a case report. Pak J Ophthalmol. 2025;41(4):456\u2013459.","journal-title":"Pak J Ophthalmol"},{"issue":"1","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3341\/kjo.2015.29.1.70","article-title":"Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure","volume":"29","author":"Lee KH","year":"2015","unstructured":"Lee KH, Han SH, Yoon JS. Successful treatment of orbital lymphangioma with intralesional bleomycin and application of continuous negative pressure. Korean J Ophthalmol. 2015;29(1):70\u201372.","journal-title":"Korean J Ophthalmol"},{"issue":"6","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaapos.2018.04.010","article-title":"A rare case of orbital lymphangioma with persistent fetal vasculature and extraorbital vascular malformations treated with intralesional bleomycin","volume":"22","author":"Hada M","year":"2018","unstructured":"Hada M, Upadhyay A, Khilnani K, Shekhawat N. A rare case of orbital lymphangioma with persistent fetal vasculature and extraorbital vascular malformations treated with intralesional bleomycin. J Aapos. 2018;22(6):471\u2013473.e1.","journal-title":"J Aapos"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1940"},{"issue":"3","key":"e_1_3_4_31_1","first-page":"1577","article-title":"Orbital vascular malformations \u2013 clinical presentation and management strategies","volume":"39","author":"Shoiab M","year":"2023","unstructured":"Shoiab M, Mehmood A. Orbital vascular malformations \u2013 clinical presentation and management strategies. Pak J Ophthalmol. 2023;39(3):1577.","journal-title":"Pak J Ophthalmol"},{"issue":"12","key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1016\/j.radcr.2023.09.008","article-title":"Sclerotherapy in orbital lymphangioma: a case report","volume":"18","author":"Aristiady EB","year":"2023","unstructured":"Aristiady EB, Hilman, Nugraha HG, Caesario MD, Kartiwa A, Susanty A. Sclerotherapy in orbital lymphangioma: a case report. Radiol Case Rep. 2023;18(12):4366\u20134369.","journal-title":"Radiol Case Rep"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002691"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-003-1058-6"},{"issue":"2","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.crad.2011.08.021","article-title":"Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery","volume":"67","author":"Shen CY","year":"2012","unstructured":"Shen CY, Wu MC, Tyan YS, Ou CH, Chen TY, Wong HF. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery. Clin Radiol. 2012;67(2):182\u2013184.","journal-title":"Clin Radiol"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1591019920972514"},{"issue":"1","key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/01676830.2018.1480636","article-title":"Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations","volume":"38","author":"Hanif AM","year":"2019","unstructured":"Hanif AM, Saunders JA, Hawkins CM, Wojno TH, Kim HJ. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations. Orbit. 2019;38(1):30\u201336.","journal-title":"Orbit"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2018-013813"},{"issue":"5","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0268355518805364","article-title":"Percutaneous sclerotherapy of para-orbital and orbital venous malformation: a single center, case series","volume":"34","author":"Ahmad S","year":"2019","unstructured":"Ahmad S, Akhtar FK. Percutaneous sclerotherapy of para-orbital and orbital venous malformation: a single center, case series. Phlebology. 2019;34(5):355\u2013361.","journal-title":"Phlebology"},{"issue":"2","key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3174\/ajnr.A5449","article-title":"Lymphographic-like technique for the treatment of microcystic lymphatic malformation components of <3 mm","volume":"39","author":"Da Ros V","year":"2018","unstructured":"Da Ros V, Iacobucci M, Puccinelli F, Spelle L, Saliou G. Lymphographic-like technique for the treatment of microcystic lymphatic malformation components of <3 mm. AJNR Am J Neuroradiol. 2018;39(2):350\u2013354.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.02.036"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001870"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01527-9"},{"issue":"10","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"e231878","DOI":"10.1001\/jamaophthalmol.2023.1878","article-title":"Lymphangiectasia hemorrhagica conjunctivae regression with bleomycin sclerotherapy on anterior-segment optical coherence tomography","volume":"141","author":"Tripathy D","year":"2023","unstructured":"Tripathy D. Lymphangiectasia hemorrhagica conjunctivae regression with bleomycin sclerotherapy on anterior-segment optical coherence tomography. JAMA Ophthalmol. 2023;141(10):e231878.","journal-title":"JAMA Ophthalmol"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002243"},{"issue":"18","key":"e_1_3_4_46_1","first-page":"160","article-title":"Conjunctival lesions: when should we perform biopsy?","volume":"9","author":"Khan L","year":"2017","unstructured":"Khan L, Malukani M, Saxena A. Conjunctival lesions: when should we perform biopsy? Nepal J Ophthalmol. 2017;9(18):160\u2013169.","journal-title":"Nepal J Ophthalmol"},{"issue":"1","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/ojo.OJO_44_2019","article-title":"Intralesional bleomycin: a treatment modality for conjunctival lymphangioma","volume":"13","author":"Bansal S","year":"2020","unstructured":"Bansal S, Das S. Intralesional bleomycin: a treatment modality for conjunctival lymphangioma. Oman J Ophthalmol. 2020;13(1):43\u201345.","journal-title":"Oman J Ophthalmol"},{"issue":"3","key":"e_1_3_4_48_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00270-018-2128-4","article-title":"Image-guided Percutaneous bleomycin and Bevacizumab sclerotherapy of orbital lymphatic malformations in children","volume":"42","author":"Abdelaziz O","year":"2019","unstructured":"Abdelaziz O, Hassan F, Elessawy K, Emad-Eldin S, Essawy RE. Image-guided Percutaneous bleomycin and Bevacizumab sclerotherapy of orbital lymphatic malformations in children. Cardiovasc Intervent Radiol. 2019;42(3):433\u2013440.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"e_1_3_4_49_1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/eye.2017.154","article-title":"Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations","volume":"32","author":"Bothra N","year":"2018","unstructured":"Bothra N, Panda L, Sheth J, Tripathy D. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations. Eye (Lond). 2018;32(1):152\u2013155.","journal-title":"Eye (Lond)"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_1691_23"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001837"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001294"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjr\/tqad008"},{"issue":"3","key":"e_1_3_4_54_1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3341\/kjo.2016.0034","article-title":"Orbital Lymphangioma: characteristics and treatment outcomes of 12 cases","volume":"31","author":"Woo YJ","year":"2017","unstructured":"Woo YJ, Kim CY, Sgrignoli B, Yoon JS. Orbital Lymphangioma: characteristics and treatment outcomes of 12 cases. Korean J Ophthalmol. 2017;31(3):194\u2013201.","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"e_1_3_4_55_1","first-page":"240","article-title":"The experience of intralesional bleomycin for orbital vascular anomalies","volume":"33","author":"Kamil Z","year":"2021","unstructured":"Kamil Z, Qurban Q, Hassan Khan MT. The experience of intralesional bleomycin for orbital vascular anomalies. J Ayub Med Coll Abbottabad. 2021;33(2):240\u2013243.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75613"},{"issue":"3","key":"e_1_3_4_57_1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1055\/s-0044-1779689","article-title":"Image-guided Percutaneous sclerotherapy for orbital low-flow malformation: our experience","volume":"34","author":"Lokdarshi G","year":"2024","unstructured":"Lokdarshi G, Kumar S, Kumar S, Nitu N, Gaur N. Image-guided Percutaneous sclerotherapy for orbital low-flow malformation: our experience. Indian J Radiol Imag. 2024;34(3):539\u2013544.","journal-title":"Indian J Radiol Imag"},{"issue":"1","key":"e_1_3_4_58_1","first-page":"1","article-title":"Intralesional bleomycin for orbital vascular malformations at a tertiary care centre","volume":"42","author":"Khan NQ","year":"2025","unstructured":"Khan NQ, Dembra WK, Khawar R. Intralesional bleomycin for orbital vascular malformations at a tertiary care centre. Pak J Ophthalmol. 2025;42(1):1\u20136.","journal-title":"Pak J Ophthalmol"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2019.05.034"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21139"},{"issue":"4","key":"e_1_3_4_61_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00270-020-02420-w","article-title":"Fatal lung toxicity after intralesional bleomycin sclerotherapy of a vascular malformation","volume":"43","author":"Cho AL","year":"2020","unstructured":"Cho AL, Kiang SC, Lodenkamp J, Tritch WTH, Tomihama RT. Fatal lung toxicity after intralesional bleomycin sclerotherapy of a vascular malformation. Cardiovasc Intervent Radiol. 2020;43(4):648\u2013651.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1787"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2014.959617"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2851"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302900"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.8229"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-025-04154-0"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2023.03.007"},{"issue":"6","key":"e_1_3_4_69_1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bjo.84.6.614","article-title":"Management of orbital lymphangioma using intralesional injection of OK-432","volume":"84","author":"Suzuki Y","year":"2000","unstructured":"Suzuki Y, Obana A, Gohto Y, Miki T, Otuka H, Inoue Y. Management of orbital lymphangioma using intralesional injection of OK-432. Br J Ophthalmol. 2000;84(6):614\u2013617.","journal-title":"Br J Ophthalmol"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-006-0510-4"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001830"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231163614"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2015.08.051"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318242ab0f"},{"issue":"9","key":"e_1_3_4_75_1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/s00247-012-2406-2","article-title":"Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy","volume":"42","author":"Shergill A","year":"2012","unstructured":"Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol. 2012;42(9):1080\u20131088.","journal-title":"Pediatr Radiol"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.PRS.0000145633.99581.98"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11055"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2014.08.012"},{"issue":"2","key":"e_1_3_4_79_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3341\/kjo.2023.0125","article-title":"Successful treatment of orbital lymphatic malformation using foam sclerotherapy with 3% sodium tetradecyl sulfate: a case report","volume":"38","author":"Jung H","year":"2024","unstructured":"Jung H, Choi HY, Lee H, Park J. Successful treatment of orbital lymphatic malformation using foam sclerotherapy with 3% sodium tetradecyl sulfate: a case report. Korean J Ophthalmol. 2024;38(2):167\u2013169.","journal-title":"Korean J Ophthalmol"},{"issue":"9","key":"e_1_3_4_80_1","first-page":"e29173","article-title":"Orbital venolymphatic malformation treated with sodium tetradecyl sulfate: a case report","volume":"14","author":"Das S","year":"2022","unstructured":"Das S, Agrawal A, Burathoki SK, Nandolia KK, Juneja A, Samanta R. Orbital venolymphatic malformation treated with sodium tetradecyl sulfate: a case report. Cureus. 2022;14(9):e29173.","journal-title":"Cureus"},{"issue":"4","key":"e_1_3_4_81_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s10384-008-0547-5","article-title":"Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate","volume":"52","author":"Poonyathalang A","year":"2008","unstructured":"Poonyathalang A, Preechawat P, Jiarakongmun P, Pongpech S. Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate. Jpn J Ophthalmol. 2008;52(4):298\u2013304.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-199911000-00013"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1177\/159101990100700303"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2019.01.002"},{"issue":"2","key":"e_1_3_4_85_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/bjophthalmol-2015-306657","article-title":"Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience","volume":"100","author":"Barnacle AM","year":"2016","unstructured":"Barnacle AM, Theodorou M, Maling SJ, Abou-Rayyah Y. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience. Br J Ophthalmol. 2016;100(2):204\u2013208.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"e_1_3_4_86_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00270-014-0971-5","article-title":"Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit","volume":"38","author":"Chiramel GK","year":"2015","unstructured":"Chiramel GK, Keshava SN, Moses V, Mammen S, David S, Sen S. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit. Cardiovasc Intervent Radiol. 2015;38(2):270\u2013279.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"e_1_3_4_87_1","first-page":"11","article-title":"Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications","volume":"28","author":"Frullini A","year":"2002","unstructured":"Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg. 2002;28(1):11\u201315.","journal-title":"Dermatol Surg"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.14639\/0392-100X-N1310"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018839"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1515\/iss-2025-0010"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1822-y"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/vop.12997"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.09.026"},{"issue":"8","key":"e_1_3_4_94_1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archophthalmol.2011.204","article-title":"Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas","volume":"129","author":"Kahana A","year":"2011","unstructured":"Kahana A, Bohnsack BL, Cho RI, Maher CO. Subtotal excision with adjunctive sclerosing therapy for the treatment of severe symptomatic orbital lymphangiomas. Arch Ophthalmol. 2011;129(8):1073\u20131076.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2017.00027"},{"issue":"8","key":"e_1_3_4_96_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archopht.122.8.1151","article-title":"Orbital venous malformations: current multidisciplinary treatment approach","volume":"122","author":"Arat YO","year":"2004","unstructured":"Arat YO, Mawad ME, Boniuk M. Orbital venous malformations: current multidisciplinary treatment approach. Arch Ophthalmol. 2004;122(8):1151\u20131158.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-1433.2004.03255.x"},{"issue":"9","key":"e_1_3_4_98_1","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/jp.2014.88","article-title":"Pulmonary hypertensive crisis following ethanol sclerotherapy for a complex vascular malformation","volume":"34","author":"Cordero-Schmidt G","year":"2014","unstructured":"Cordero-Schmidt G, Wallenstein MB, Ozen M, et al. Pulmonary hypertensive crisis following ethanol sclerotherapy for a complex vascular malformation. J Perinatol. 2014;34(9):713\u2013715.","journal-title":"J Perinatol"},{"issue":"4","key":"e_1_3_4_99_1","first-page":"272","article-title":"Role of interventional radiology in patients with different orbital vascular lesions: a case series","volume":"13","author":"Das I","year":"2024","unstructured":"Das I, Baruah P, Baishya PP, Kumar S. Role of interventional radiology in patients with different orbital vascular lesions: a case series. Int J Life Sci Biotechnol Pharma Res. 2024;13(4):272\u2013276.","journal-title":"Int J Life Sci Biotechnol Pharma Res"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101456"},{"issue":"4","key":"e_1_3_4_101_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0301-4738.98722","article-title":"Intralesional bleomycin for the treatment of periocular capillary hemangiomas","volume":"60","author":"Smit DP","year":"2012","unstructured":"Smit DP, Meyer D. Intralesional bleomycin for the treatment of periocular capillary hemangiomas. Indian J Ophthalmol. 2012;60(4):326\u2013328.","journal-title":"Indian J Ophthalmol"},{"key":"e_1_3_4_102_1","first-page":"218","article-title":"Dermoids and epidermoids of the orbit","volume":"46","author":"Pfeiffer RL","year":"1948","unstructured":"Pfeiffer RL, Nicholl RJ. Dermoids and epidermoids of the orbit. Trans Am Ophthalmol Soc. 1948;46:218\u2013243.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2007.02.001"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000166"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_3086_24"},{"issue":"1","key":"e_1_3_4_106_1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s43055-023-01123-9","article-title":"Case series of intraorbital colobomatous cysts with anophthalmos\/microphthalmos spectrum: a rare diagnostic conundrum simplified","volume":"54","author":"Ranga A","year":"2023","unstructured":"Ranga A, Yadav R, Bansal N, Gupta J, Bhayana A. Case series of intraorbital colobomatous cysts with anophthalmos\/microphthalmos spectrum: a rare diagnostic conundrum simplified. Egypt J Radiol Nucl Med. 2023;54(1):172.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/23320885.2020.1835485"},{"issue":"2","key":"e_1_3_4_108_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/01676830.2019.1611882","article-title":"Management of orbital conjunctival epithelial inclusion cyst using trichloroacetic acid (20%) in an outpatient setting","volume":"39","author":"Gallagher D","year":"2020","unstructured":"Gallagher D, Power B, Hughes E, Fulcher T. Management of orbital conjunctival epithelial inclusion cyst using trichloroacetic acid (20%) in an outpatient setting. Orbit. 2020;39(2):147\u2013149.","journal-title":"Orbit"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000169252.22458.5e"},{"issue":"2","key":"e_1_3_4_110_1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/01676830802595042","article-title":"Role of trichloroacetic acid in treating posterior conjunctival cyst in an anopthalmic socket","volume":"28","author":"S\u00e1nchez EM","year":"2009","unstructured":"S\u00e1nchez EM, Formento NA, P\u00e9rez-L\u00f3pez M, Jim\u00e9nez AA. Role of trichloroacetic acid in treating posterior conjunctival cyst in an anopthalmic socket. Orbit. 2009;28(2\u20133):101\u2013103.","journal-title":"Orbit"},{"issue":"2","key":"e_1_3_4_111_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/01676830.2019.1631358","article-title":"Trichloroacetic acid 10% injection for treatment of conjunctival inclusion cysts","volume":"39","author":"Bagheri A","year":"2020","unstructured":"Bagheri A, Shahraki K, Yazdani S. Trichloroacetic acid 10% injection for treatment of conjunctival inclusion cysts. Orbit. 2020;39(2):107\u2013111.","journal-title":"Orbit"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2009.07.006"},{"issue":"11","key":"e_1_3_4_113_1","first-page":"e74185","article-title":"Recurring giant conjunctival cyst effectively treated with 20% trichloroacetic acid","volume":"16","author":"L\u00f3pez-Fontanet JJ","year":"2024","unstructured":"L\u00f3pez-Fontanet JJ, Ruiz S, Torres AG, Blasini M, Rodriguez Rosa R. Recurring giant conjunctival cyst effectively treated with 20% trichloroacetic acid. Cureus. 2024;16(11):e74185.","journal-title":"Cureus"},{"issue":"5","key":"e_1_3_4_114_1","first-page":"191","article-title":"Treatment of postenucleation orbital cysts","volume":"18","author":"Hanig CJ","year":"1986","unstructured":"Hanig CJ, Hornblass A. Treatment of postenucleation orbital cysts. Ann Ophthalmol. 1986;18(5):191\u2013193.","journal-title":"Ann Ophthalmol"},{"issue":"3","key":"e_1_3_4_115_1","first-page":"191","article-title":"Treatment of conjunctival cysts in anophthalmic socket with intralesional injection of trichloroacetic acid (ATA) 25%","volume":"72","author":"Fonseca FL","year":"2013","unstructured":"Fonseca FL, Ramos RIP, Matayoshi S. Treatment of conjunctival cysts in anophthalmic socket with intralesional injection of trichloroacetic acid (ATA) 25%. Rev Bras Oftalmol. 2013;72(3):191\u2013193.","journal-title":"Rev Bras Oftalmol"},{"issue":"7","key":"e_1_3_4_116_1","first-page":"e41570","article-title":"Foam sclerotherapy for conjunctival inclusion cyst post evisceration","volume":"15","author":"Thomas R","year":"2023","unstructured":"Thomas R, Grover A. Foam sclerotherapy for conjunctival inclusion cyst post evisceration. Cureus. 2023;15(7):e41570.","journal-title":"Cureus"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.IOP.0000155509.54813.93"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2015.06.003"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.11.030"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e3180987243"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2016.08.008"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-200103000-00006"},{"issue":"4","key":"e_1_3_4_123_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/01676830.2018.1544262","article-title":"Dacryocystosclerotherapy as an alternative to dacryocystectomy","volume":"38","author":"Ali MJ","year":"2019","unstructured":"Ali MJ, Dave TV, Mishra DK, Naik MN. Dacryocystosclerotherapy as an alternative to dacryocystectomy. Orbit. 2019;38(4):300\u2013304.","journal-title":"Orbit"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02343077"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.3.438"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13258"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000660"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000173"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/asjof\/ojab048"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001332"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.931"},{"issue":"6","key":"e_1_3_4_132_1","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejvs.2020.01.023","article-title":"Bleomycin polidocanol foam (BPF) stability - in vitro evidence for the effectiveness of a novel sclerosant for venous malformations","volume":"59","author":"Sun Y","year":"2020","unstructured":"Sun Y, Gu H, Yang X, et al. Bleomycin polidocanol foam (BPF) stability - in vitro evidence for the effectiveness of a novel sclerosant for venous malformations. Eur J Vasc Endovasc Surg. 2020;59(6):1011\u20131018.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.47391\/JPMA.10601"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-015-0607-0"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.13.11351"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1148\/rg.281075040"},{"issue":"2","key":"e_1_3_4_137_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0030-1253521","article-title":"A step-by-step practical approach to imaging diagnosis and interventional radiologic therapy in vascular malformations","volume":"27","author":"Legiehn GM","year":"2010","unstructured":"Legiehn GM, Heran MK. A step-by-step practical approach to imaging diagnosis and interventional radiologic therapy in vascular malformations. Semin Intervent Radiol. 2010;27(2):209\u2013231.","journal-title":"Semin Intervent Radiol"},{"issue":"12","key":"e_1_3_4_138_1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archopht.125.12.1635","article-title":"Noninvasive dynamic magnetic resonance angiography with time-resolved imaging of contrast KineticS (TRICKS) in the evaluation of orbital vascular lesions","volume":"125","author":"Kahana A","year":"2007","unstructured":"Kahana A, Lucarelli MJ, Grayev AM, Van Buren JJ, Burkat CN, Gentry LR. Noninvasive dynamic magnetic resonance angiography with time-resolved imaging of contrast KineticS (TRICKS) in the evaluation of orbital vascular lesions. Arch Ophthalmol. 2007;125(12):1635\u20131642.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2026.1730495"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.01.003"},{"issue":"5","key":"e_1_3_4_141_1","doi-asserted-by":"crossref","first-page":"W439","DOI":"10.2214\/AJR.09.3416","article-title":"Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations","volume":"194","author":"Li L","year":"2010","unstructured":"Li L, Zeng XQ, Li YH. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations. AJR Am J Roentgenol. 2010;194(5):W439\u201344.","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"e_1_3_4_142_1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1177\/02683555221125596","article-title":"Skin necrosis following sclerotherapy. Part 2: risk minimisation and management strategies","volume":"37","author":"Kang M","year":"2022","unstructured":"Kang M, Yang A, Hannaford P, Connor D, Parsi K. Skin necrosis following sclerotherapy. Part 2: risk minimisation and management strategies. Phlebology. 2022;37(9):628\u2013643.","journal-title":"Phlebology"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4518"},{"issue":"10","key":"e_1_3_4_144_1","first-page":"1792","article-title":"Navigation-assisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations","volume":"25","author":"Ernemann U","year":"2004","unstructured":"Ernemann U, Westendorff C, Troitzsch D, Hoffmann J. Navigation-assisted sclerotherapy of orbital venolymphatic malformation: a new guidance technique for percutaneous treatment of low-flow vascular malformations. AJNR Am J Neuroradiol. 2004;25(10):1792\u20131795.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000009563"},{"issue":"8","key":"e_1_3_4_146_1","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1136\/neurintsurg-2015-011777.rep","article-title":"Transvenous sclerotherapy of a large symptomatic orbital venous varix using a microcatheter balloon and bleomycin","volume":"8","author":"Vadlamudi V","year":"2016","unstructured":"Vadlamudi V, Gemmete JJ, Chaudhary N, Pandey AS, Kahana A. Transvenous sclerotherapy of a large symptomatic orbital venous varix using a microcatheter balloon and bleomycin. J Neurointerv Surg. 2016;8(8):e30.","journal-title":"J Neurointerv Surg"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002085"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1159\/000531601"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2018.09.009"},{"issue":"2","key":"e_1_3_4_150_1","first-page":"280","article-title":"Orbital venous lymphatic malformations: case series on minimally invasive treatment approach","volume":"69","author":"Ranjan A","year":"2025","unstructured":"Ranjan A, Chhabra AK, Kumar M. Orbital venous lymphatic malformations: case series on minimally invasive treatment approach. Rom J Ophthalmol. 2025;69(2):280\u2013286.","journal-title":"Rom J Ophthalmol"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2018.08.016"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08820538.2026.2727974","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/08820538.2026.2727974","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/08820538.2026.2727974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T12:50:43Z","timestamp":1788699043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/08820538.2026.2727974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":150,"alternative-id":["10.1080\/08820538.2026.2727974"],"URL":"https:\/\/doi.org\/10.1080\/08820538.2026.2727974","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}